Observational study identifies low omega-3 and high omega-6 fatty acids as cardiovascular risks in hemodialysis patients, suggesting novel intervention avenues.
Persons treated with maintenance hemodialysis (HD) are at high risk of serious cardiovascular (CV) events. We hypothesized that low levels of omega-3 polyunsaturated fatty acids (n-3 PUFA; eicosapentaenoic acid [EPA] and docosahexaenoic acid [DHA]) and high levels of omega-6 fatty acids (arachidonic acids [AA]) in patients treated with HD are novel risk factors for CV events.
No takes yet. Share an insight, caveat, or question.
Tomlinson et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: